Showing results (351-360 of 1,251) with videos related to
Sort By:
Pageof 126
Journal of Molecular Modeling|December 11, 2008
Structural, IR, and EPR studies of the bis(methoxyacetato)diaquo-copper(II) complexZ Alimohammadi, H Rahemi, M Golzan, et al.Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|September 1, 1987
Is insulin-dependent diabetes mellitus a preventable disease?N K Maclaren, W J Riley, W E Winter, et al.Critical Reviews in Toxicology|November 3, 2017
Assessing cancer hazards of bitumen emissions - a case study for complex petroleum substancesAnthony J Kriech, Ceinwen A Schreiner, Linda V Osborn, et al.Veterinary Pathology|November 1, 1989
Dyspnea in aging rats due to disseminated intravascular coagulation (DIC)P Carthew, P Aldred, R J Hill, et al.Archives of Toxicology|May 7, 2020
The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and developmentPaul A Walker, Stephanie Ryder, Andrea Lavado, et al.Autoimmunity|January 1, 1988
Polyclonal nature of islet cell antibodies in insulin-dependent diabetesD A Schatz, D J Barrett, N K Maclaren, et al.Biology of the Neonate|May 15, 1999
Remodeling of rat neonatal pulmonary artery: role of matrix metalloproteinasesC A Tozzi, S Thakker-Varia, M S Dice, et al.Proceedings of the National Academy of Sciences of the United States of America|January 9, 1996
Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6P L Chen, D J Riley, S Chen-Kiang, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 5, 2006
The development of a cocktail CYP2B6, CYP2C8, and CYP3A5 inhibition assay and a preliminary assessment of utility in a drug discovery settingCharles J O'Donnell, Ken Grime, Paul Courtney, et al.Translational Medicine Communications|August 25, 2020
COVID-19 related deaths in an urban academic medical center in Brooklyn - a descriptive case seriesJames Andrew McCracken, Mohamed Nakeshbandi, Jeffrey Arace, et al.Pageof 126